Ganglioside GD1a suppression of NOS2 expression via ERK1 pathway in mouse osteosarcoma FBJ cells

Journal of Cellular Biochemistry

Volumn 110, Issue 5, 2010, Pages 1165-1174

  Cao, Ting ^a   Zhang, Tianyi ^a   Wang, Li ^a   Zhang, Lan ^a   Adachi, Tomoko ^b   Sato, Toshinori ^c   Yamagata, Sadako ^a   Yamagata, Tatsuya ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b NAGOYA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

ERK1 2; FBJ osteosarcoma cells; GD1a; GT1b; NOS2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GANGLIOSIDE; GANGLIOSIDE GD 1A; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; GENE SILENCING; GM2 GANGLIOSIDOSIS; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; BUTADIENES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME INHIBITORS; FLAVONOIDS; GANGLIOSIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE TYPE II; NITRILES; OSTEOSARCOMA; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

MURINAE;

EID: 77954925666     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22631     Document Type: Article

References (40)

1. Afework M, Lincoln J, Belai A, Burnstock G. 1996. Increase in nitric oxide synthase and NADPH-diaphorase in the adrenal gland of streptozotocindiabetic Wistar rats and its prevention by ganglioside. Int J Dev Neurosci 14:111-123. (Pubitemid 26140701)
2. Andrew PJ, Mayer B. 1999. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43:521-531. (Pubitemid 29369251)
3. Bhat NR, Zhang P, Lee JC, Hogan EL. 1998. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641. (Pubitemid 28103071)
4. Bremer EG, Hakomori S, Bowen-Pope DF, Raines E, Ross R. 1984. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem 259:6818-6825. (Pubitemid 14078977)
5. Chan ED, Riches DW. 2001. IFN-gamma+LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 280:C441-C450.
6. Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH. 2009. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2. Glycobiology 19:229-239.
7. Cobb MH, Goldsmith EJ. 1995. How MAP kinases are regulated. J Biol Chem 270:14843-14846.
8. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. 1995. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55:727-730.
9. Crowell JA, Steele VE, Sigman CC, Fay JR. 2003. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2:815-823.
10. Da Silva J, Pierrat B, Mary JL, Lesslauer W. 1997. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380. (Pubitemid 27517783)
11. Furian AF, Oliveira MS, Magni DV, Souza MA, Bortoluzzi VT, Bueno LM, Royes LF, Mello CF. 2008. L-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain. Neurochem Int 53:362-369.
12. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M. 1998. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90:587-596. (Pubitemid 28204802)
13. Gu Y, Zhang J, Mi W, Yang J, Han F, Lu X, Yu W. 2008. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res 10:R1.
14. Hakomori S. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56:5309-5318. (Pubitemid 27011703)
15. Hu D, Man Z, Wang P, Tan X, Wang X, Takaku S, Hyuga S, Sato T, Yao X, Yamagata S, Yamagata T. 2007. Ganglioside GD1a negatively regulates matrix metalloproteinase-9 expression in mouse FBJ cell lines at the transcriptional level. Connect Tissue Res 48:198-205.
16. Hua LL, Zhao ML, Cosenza M, Kim MO, Huang H, Tanowitz HB, Brosnan CF, Lee SC. 2002. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol 126:180-189.
17. Hyuga S, Yamagata S, Tai T, Yamagata T. 1997. Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells. Biochem Biophys Res Commun 231:340-343. (Pubitemid 27214308)
18. Hyuga S, Yamagata S, Takatsu Y, Hyuga M, Nakanishi H, Furukawa K, Yamagata T. 1999. Suppression by ganglioside GD1A of migration capability, adhesion to vitronectin and metastatic potential of highly metastatic FBJ-LL cells. Int J Cancer 83:685-691. (Pubitemid 29508051)
19. Hyuga S, Kawasaki N, Hyuga M, Ohta M, Shibayama R, Kawanishi T, Yamagata S, Yamagata T, Hayakawa T. 2001. Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met. Int J Cancer 94:328-334. (Pubitemid 32906061)
20. Kawashima N, Yoon SJ, Itoh K, Nakayama K. 2009. Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem 284:6147-6155.
21. Keynes RG, Garthwaite J. 2004. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 4:179-191. (Pubitemid 38425913)
22. Kim CO, Huh AJ, Kim MS, Chin BS, Han SH, Choi SH, Jeong SJ, Choi HK, Choi JY, Song YG, Kim JM. 2008. LPS-induced vascular endothelial growth factor expression in rat lung pericytes. Shock 30:92-97.
23. Korhonen R, Linker K, Pautz A, Forstermann U, Moilanen E, Kleinert H. 2007. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol Pharmacol 71:1427-1434. (Pubitemid 46658695)
24. Lagares-Garcia JA, Moore RA, Collier B, Heggere M, Diaz F, Qian F. 2001. Nitric oxide synthase as a marker in colorectal carcinoma. Am Surg 67:709-713. (Pubitemid 33739094)
25. Lang Z, Guerrera M, Li R, Ladisch S. 2001. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem Biophys Res Commun 282:1031-1037. (Pubitemid 32924599)
26. Liu Y, Li R, Ladisch S. 2004. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J Biol Chem 279:36481-36489. (Pubitemid 39128989)
27. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S. 2005. A specific microdomain (''glycosynapse 3'') controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3-beta1 integrin with CD9. J Biol Chem 280:35545-35553.
28. Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN. 2008. Thematic review series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. J Lipid Res 49:929-938.
29. Prinetti A, Aureli M, Illuzzi G, Prioni S, Nocco V, Scandroglio F, Gagliano N, Tredici G, Rodriguez-Menendez V, Chigorno V, Sonnino S. 2010. GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology 20:62-77.
30. Song ZJ, Gong P, Wu YE. 2002. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 8:591-595.
31. Thil MA, Vince V, Veraart C, Delbeke J, Colin IM. 2005. Nitric oxide synthases II and III and vascular endothelial growth factor are up-regulated in sciatic nerve after spiral cuff electrode implantation. J Neuroimmunol 166:158-166.
32. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. 1995. Nitric oxide synthase activity in human breast cancer. Br J Cancer 72:41-44.
33. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. 2007. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282:8123-8133.
34. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. 2008. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci USA 105:1925-1930.
35. Wang L, Takaku S, Wang P, Hu D, Hyuga S, Sato T, Yamagata S, Yamagata T. 2006. Ganglioside GD1a regulation of caveolin-1 and Stim1 expression in mouse FBJ cells: Augmented expression of caveolin-1 and Stim1 in cells with increased GD1a content. Glycoconj J 23:303-315. (Pubitemid 44198255)
36. Wang L, Wang Y, Sato T, Yamagata S, Yamagata T. 2008. Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells. Biochem Biophys Res Commun 371:230-235.
37. Wright B, Lacchini AH, Davies AJ, Walker AJ. 2006. Regulation of nitric oxide production in snail (Lymnaea stagnalis) defence cells: A role for PKC and ERK signalling pathways. Biol Cell 98:265-278.
38. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
39. Yamagata S, Ito Y, Tanaka R, Shimizu S. 1988. Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun 151:158-162. (Pubitemid 18074157)
40. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. 1997. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634. (Pubitemid 27259809)